glucose, (beta-d)-isomer has been researched along with tacrolimus in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Didlake, R; Grogan, J | 1 |
| Leduc, D; Pretolani, M; Vargaftig, BB; Zuany-Amorim, C | 1 |
| Bermudez, LE; Egawa, H; Esquivel, CO; Hayashi, M; So, SK; Tojimbara, T | 1 |
| Asselin, I; Célestin, F; Entman, M; Goulet, M; Guérette, B; Huard, C; Roy, B; Roy, R; Skuk, D; Tardif, F; Tremblay, JP | 1 |
| Li, DJ; Shan, SG; Sun, Y | 1 |
| Goebel, AS; Neubert, RH; Wohlrab, J | 1 |
| Borowiec, A; Dadlez, M; Hryniewiecka, E; Jaźwiec, R; Pączek, L; Pawłowska, E; Tszyrsznic, W; Zegarska, J; Żochowska, D | 1 |
| Chung, BH; Jin, J; Jin, L; Lim, SW; Luo, K; Yang, CW | 1 |
| Deng, Y; Huang, H; Li, S; Peng, L; Wang, B; Yang, R; Yuan, J; Zhang, H; Zhong, J | 1 |
| Attallah, N; Yassine, L | 1 |
10 other study(ies) available for glucose, (beta-d)-isomer and tacrolimus
| Article | Year |
|---|---|
Effect of FK 506 on rat leukocyte chemotaxis.
Topics: Animals; Chemotaxis, Leukocyte; Dose-Response Relationship, Drug; In Vitro Techniques; Leukocytes, Mononuclear; Lymphocytes; Macrophages; Rats; Rats, Inbred Strains; Tacrolimus; Zymosan | 1991 |
Characterization and pharmacological modulation of antigen-induced peritonitis in actively sensitized mice.
Topics: Animals; Benzeneacetamides; Cetirizine; Cycloheximide; Dexamethasone; Eosinophils; Histamine Release; Hydroxamic Acids; Indomethacin; Kinetics; Leukocyte Count; Leukotriene B4; Leukotriene C4; Lipoxygenase Inhibitors; Male; Mice; Mice, Inbred BALB C; Ovalbumin; Peritoneal Cavity; Peritonitis; Platelet Activating Factor; T-Lymphocytes; Tacrolimus; Terfenadine; Thiazoles; Zymosan | 1993 |
Cyclosporine and tacrolimus both suppress activation of Kupffer cells in vitro.
Topics: Animals; Cells, Cultured; Cyclosporine; Immunosuppressive Agents; Kupffer Cells; Macrophage Activation; Male; Rats; Rats, Wistar; Superoxides; Tacrolimus; Tumor Necrosis Factor-alpha; Zymosan | 1996 |
Prevention by anti-LFA-1 of acute myoblast death following transplantation.
Topics: Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Apoptosis; beta-Galactosidase; Biomarkers; Cell Adhesion; Cell Death; Cell Line, Transformed; Fluoresceins; Genes, Reporter; Graft Rejection; Immunosuppressive Agents; Inflammation; Interleukin-1; Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen; Methylprednisolone; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred mdx; Mice, SCID; Muscle, Skeletal; Muscular Dystrophy, Animal; Naproxen; Necrosis; Neutrophils; Oxidative Stress; Peroxidase; Piroxicam; Radiation Chimera; Stem Cell Transplantation; Tacrolimus; Whole-Body Irradiation; Zymosan | 1997 |
[Total glucosides of peony as adjuvant therapy for prevention of cardiac allograft rejection in rats].
Topics: Animals; Combined Modality Therapy; Glucosides; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Paeonia; Random Allocation; Rats; Rats, Sprague-Dawley; Rats, Wistar; Tacrolimus | 2007 |
Dermal targeting of tacrolimus using colloidal carrier systems.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chick Embryo; Chorioallantoic Membrane; Colloids; Drug Carriers; Drug Compounding; Female; Glucosides; Humans; Kinetics; Lecithins; Light; Ointments; Permeability; Scattering, Radiation; Skin; Skin Absorption; Solubility; Solvents; Surface-Active Agents; Tacrolimus; Technology, Pharmaceutical | 2011 |
Mycophenolic Acid Metabolites Acyl-Glucuronide and Glucoside Affect the Occurrence of Infectious Complications and Bone Marrow Dysfunction in Liver Transplant Recipients.
Topics: Adult; Bacterial Infections; Cyclosporine; Female; Glucosides; Glucuronides; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Tacrolimus; Transplant Recipients | 2015 |
Effect of Empagliflozin on Tacrolimus-Induced Pancreas Islet Dysfunction and Renal Injury.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Glucosides; Glycosuria; Humans; Hypoglycemic Agents; Insulin; Islets of Langerhans; Kidney; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium-Glucose Transporter 2; Tacrolimus | 2017 |
Tacrolimus interacts with voriconazole to reduce the severity of fungal keratitis by suppressing IFN-related inflammatory responses and concomitant FK506 and voriconazole treatment suppresses fungal keratitis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cornea; Disease Models, Animal; Drug Combinations; Drug Synergism; Epithelial Cells; Eye Infections, Fungal; Female; Gene Expression Regulation; Interferons; Interleukins; Keratitis; Lymphocytes; Macrophages; Mice; Mice, Inbred C57BL; Neutrophils; Severity of Illness Index; Tacrolimus; Voriconazole; Zymosan | 2018 |
Use of Empagliflozin in Recipients of Kidney Transplant: A Report of 8 Cases.
Topics: Adult; Benzhydryl Compounds; Calcineurin Inhibitors; Diabetes Mellitus; Female; Glucosides; Glycated Hemoglobin; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors; Tacrolimus; Treatment Outcome | 2019 |